首页> 外国专利> METHOD FOR VITRECTOMY AT THE PROLIFERATIVE DIABETIC RETINOPATHY, COMPLICATED BY HEMOPHTHALMIA

METHOD FOR VITRECTOMY AT THE PROLIFERATIVE DIABETIC RETINOPATHY, COMPLICATED BY HEMOPHTHALMIA

机译:增生性糖尿病视网膜病变的玻璃体切除术

摘要

A method for vitrectomy at the proliferative diabetic retinopathy, complicated by hemophthalmia, consists in ablation of posterior galoid membrane and in performing the endolaser coagulation of nervous tunic of eyeball. The central vitrectomy is carried out unde the infusion pressure of HO, after visualization of optic disc and retina central artery an operation is performed under the pressure of infusion, which equal the systole pressure in the retina central artery, lowered in HO. The dissection of basal vitreal gel is carried out directly after the cut of posterior galoid membrane in the corresponding merediane. The endolaser coagulation is carried out at the filling of vitreous body cavity and posterior chamber with perfluoro carboxylic liquid under the pressure of infusion, which equal the systole pressure in the retina central artery, lowered in HO.
机译:在增生性糖尿病性视网膜病变并发眼炎的情况下进行玻璃体切除的方法包括消融后盖状囊膜和进行眼内神经束内膜激光凝结。中央玻璃体切除术是根据HO的输注压力进行的,在视盘和视网膜中央动脉可视化之后,在输注压力下进行手术,输注压力等于HO降低的视网膜中央动脉的收缩压。玻璃体基底胶体的解剖是在相应的金盏花中切开后方胆囊膜后进行的。激光内凝是在玻璃体腔和后房充满全氟羧酸液体的情况下在输注压力下进行的,该输注压力等于视网膜中央动脉的收缩压,降低了HO。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号